Electrophysiological measures as biomarkers of disease progression and outcome in psychoses

Talks

From one-size-fits-all psychiatry to stratified psychiatry: Brain markers and heart-brain-coupling
Martijn Arns, PhD
Done
The condition and perturb approach, a new protocol for preoperative language mapping in patients with brain tumors: First results of intraoperative validation
Tammam Abboud, MD
Done
Language mapping on patients with parenchymatous tumor in language eloquent areas
Jimmy Landry Zepa Yotedje
Done
Phase-amplitude coupling in EEG as a Parkinsonian biomarker
Prof. Thomas R. Knösche
Done
Real brains in virtual worlds
Prof. Klaus Gramann
Done
Mapping and targeting with TMS
Prof. Thomas Knösche
Done
Atypical neural processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risk
Prof. Sophie Molholm
Done
Towards personalised neuromodulation in mental health: A non-invasive avenue of network research into dynamic brain circuits and their dysfunction
Prof. Marcus Kaiser
Done
High-fidelity continuous monitoring of physiology anywhere with RDS
Louis Mayaud, PhD
Done
Own data, not hardware
Cecilia Mazzetti, PhD
Done

11/3/22, 11:50 AM - 11/3/22, 12:20 PM (Europe/Amsterdam) (30 minutes)

Prof. Giorgio Di Lorenzo

Associate Professor of Psychiatry, Laboratory of Psychophysiology and Cognitive Neuroscience, Department of Systems Medicine University of Rome Tor Vergata

Giorgio Di Lorenzo, M.D., Ph.D., is an Associate Professor of Psychiatry and directs the Laboratory of

Psychophysiology and Cognitive Neuroscience (PsyCoNeLab), at the Department of Systems Medicine of the University of Rome Tor

Vergata. The main field of interest is in the clinical application of EEG recording as a tool for the investigation of the pathophysiology

of brain connectivity in mental disorders (mainly psychosis, autism, and trauma-related disorders), as well as the examination

of neurophysiological changes induced by psychopharmacological, psychotherapeutic, brain electromagnetic stimulation and

modulation, and rehabilitative treatments.

The use of electroencephalography (EEG) as a tool to discriminate people with or without psychosis has failed until now.

The heterogeneity in psychopathological features and outcomes in subjects with psychosis has led to the search for biomarkers that

could improve the diagnostic and prognostic processes. In recent years, research in psychosis has highlighted how abnormalities of

electrophysiological indices could be associated with clinical features, the outcome, and the risk of psychosis. Within this frame, Di

Lorenzo will present the results of recent, large, and multicenter studies that use EEG indices in subjects with psychosis, discussing their

use as potential biomarkers. Di Lorenzo will also offer a critical viewpoint for translating EEG research into clinical practice to facilitate the

early diagnosis and identify markers of progression, prognosis, and treatment of this severe illness.